N. E. Gulcelik Et Al. , "The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis," Minerva endocrinology , vol.48, no.4, pp.379-386, 2023
Gulcelik, N. E. Et Al. 2023. The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis. Minerva endocrinology , vol.48, no.4 , 379-386.
Gulcelik, N. E., Akin, S., Aydin, K., Aydin Mericoz, C., Guler Tezel, Y. G., & Usman, A., (2023). The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis. Minerva endocrinology , vol.48, no.4, 379-386.
Gulcelik, Nese Et Al. "The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis," Minerva endocrinology , vol.48, no.4, 379-386, 2023
Gulcelik, Nese E. Et Al. "The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis." Minerva endocrinology , vol.48, no.4, pp.379-386, 2023
Gulcelik, N. E. Et Al. (2023) . "The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis." Minerva endocrinology , vol.48, no.4, pp.379-386.
@article{article, author={Nese E. Gulcelik Et Al. }, title={The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis}, journal={Minerva endocrinology}, year=2023, pages={379-386} }